Policy Mahotsav 2.0, held on 23rd May 2025 at the Constitution Club of India, concluded with resounding success, reinforcing India’s pivotal role in shaping the global MedTech narrative. Centered on the theme “Policy, Regulation, and Public Good: Building the MedTech Industry for Tomorrow’s Healthcare,” the
HealthCare Global Enterprises Limited (HCG), the leading specialty healthcare service provider in India, focused on oncology, announced the acquisition of oncology hospital labs and clinical trials business from Strand Lifesciences as well as simultaneous divestment of its ~38.5% stake (on paid-up capital basis and 34.5%
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
